MINI FUTURE LONG - STRYKER CORP. Share Price

Certificat

DE000PD5W5X6

Market Closed - Bid/Ask 20:41:31 30/04/2024 BST
15.07 EUR -0.59% Intraday chart for MINI FUTURE LONG - STRYKER CORP.
Current month-10.51%
1 month-10.51%
Date Price Change Volume
30/04/24 15.07 -0.59% 0
29/04/24 15.16 +1.54% 0
26/04/24 14.93 -0.80% 0
25/04/24 15.05 0.00% 0
24/04/24 15.05 +1.76% 0

Delayed Quote Börse Stuttgart

Last update April 30, 2024 at 08:41 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5W5X
ISINDE000PD5W5X6
Date issued 12/05/2022
Strike 176.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 7.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.08
Lowest since issue 3.45
Spread 0.03
Spread %0.20%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
338.9 USD
Average target price
365.7 USD
Spread / Average Target
+7.91%
Consensus